Levetiracetam as a treatment for tardive dyskinesia: A case report

被引：24

作者：

McGavin, CL ^{[1
]}

John, V ^{[1
]}

Musser, WS ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA

来源：

NEUROLOGY | 2003年 / 61卷 / 03期

关键词：

D O I：

10.1212/01.WNL.0000073538.60021.50

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：419 / 420

页数：2

共 7 条

[1] Piracetam in the treatment of tardive dyskinesia and akathisia: A case report [J].

Fehr, C ;

Dahmen, N ;

Klawe, C ;

Eicke, M ;

Szegedi, A .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (02) :248-249

[2]

Ghadirian AM, 1996, J CLIN PSYCHIAT, V57, P22

[3] The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata [J].

Loscher, W ;

Honack, D ;

BlomsFunke, P .

BRAIN RESEARCH, 1996, 735 (02) :208-216

[4] Selective blockade of N-type calcium channels by levetiracetam [J].

Lukyanetz, EA ;

Shkryl, VM ;

Kostyuk, PG .

EPILEPSIA, 2002, 43 (01) :9-18

[5] ASSESSMENT OF EXTRAPYRAMIDAL DISORDERS [J].

MARSDEN, CD ;

SCHACHTER, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (02) :129-151

[6] Levetiracetam [J].

Nash, EM ;

Sangha, KS .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (13) :1195-1199

[7] Anatomy, physiology and pharmacology of the basal ganglia [J].

Pollack, AE .

NEUROLOGIC CLINICS, 2001, 19 (03) :523-+

← 1 →